Graticule Asia Macro Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Graticule Asia Macro Advisors's PFE Position: Q3 2026 in Review
Graticule Asia Macro Advisors sold out of Pfizer (PFE) in Q3 2026, closing a stake of 5,561 shares — an estimated $134K sold.
Graticule Asia Macro Advisors first reported a position in PFE in Q1 2017 and held it in 2 quarters. The position peaked at $1.98M in Q1 2017. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Graticule Asia Macro Advisors reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
- Graticule Asia Macro Advisors sold 5,561 Pfizer shares in Q3 2026, an estimated $134K.
- Graticule Asia Macro Advisors first reported a position in Pfizer in Q1 2017 and held it in 2 quarters.
- Graticule Asia Macro Advisors's Pfizer position peaked at $1.98M in Q1 2017.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Graticule Asia Macro Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.